Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

Market Cap	11.14B -26.4%
Revenue (ttm)	1.05B +37.3%
Net Income	92.75M
EPS	0.22
Shares Out	442.34M
PE Ratio	114.25
Forward PE	n/a
Dividend	0.06 (0.23%)
Ex-Dividend Date	May 14, 2026

Volume	6,768,989
Open	25.55
Previous Close	25.29
Day's Range	25.10 - 25.75
52-Week Range	23.41 - 38.69
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the pharmaceutical industry in China. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for peripheral T-cell lymphoma, breast cancer, and diffuse large B-cell lymphoma indications; Chiglitazar, a PPAR full agonist for diabetes treatment; Siglitazone for metabolism treatment area; and Cioronib, a novel molecular, which selectively inhibits tumor-related protein kinase targets. It is also involved in the development of CS23546, a small molecule PD-L1 inhibitor, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,002
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688321

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error